title: Indinavir-related recurrent paronychia and ingrown toenails.
abstract: Lamivudine and indinavir are two medications used to treat human immunodeficiency virus (HIV) that have recently been reported to cause paronychia. The nails of the great toes are commonly affected. This is the second report of paronychia and ingrown toenails due to indinavir and the first report of recurrent paronychia and ingrown toenails associated with this drug.
authors.affiliation: Department of Dermatology, New York-Presbyterian Hospital, Columbia Presbyterian Center, New York, USA.
authors.forename: M
authors.initials: M
authors.lastname: Alam
authors.forename: R K
authors.initials: RK
authors.lastname: Scher
mesh_terms: D000328:Adult; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D015497:HIV-1 / Q000302:isolation & purification*; D006801:Humans; D019469:Indinavir / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009263:Nails, Ingrown / Q000139:chemically induced* / Q000503:physiopathology; D010304:Paronychia / Q000139:chemically induced* / Q000503:physiopathology; D012008:Recurrence; D014034:Toes
chemical_list: D017320:HIV Protease Inhibitors; D019469:Indinavir